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Stem cells undergo a shift in metabolic substrate uti-
lization during specification and/or differentiation, a
process that has been termed metabolic reprogram-
ming. Here, we report that during the transition from
quiescence to proliferation, skeletal muscle stem
cells experience a metabolic switch from fatty acid
oxidation to glycolysis. This reprogramming of
cellular metabolism decreases intracellular NAD+
levels and the activity of the histone deacetylase
SIRT1, leading to elevated H4K16 acetylation and
activation ofmuscle gene transcription. Selective ge-
netic ablation of the SIRT1 deacetylase domain in
skeletal muscle results in increased H4K16 acetyla-
tion and deregulated activation of the myogenic pro-
gram in SCs. Moreover, mice with muscle-specific
inactivation of the SIRT1 deacetylase domain display
reduced myofiber size, impaired muscle regenera-
tion, and derepression of muscle developmental
genes. Overall, these findings reveal how metabolic
cues can be mechanistically translated into epige-
netic modifications that regulate skeletal muscle
stem cell biology.
INTRODUCTION
Cellular energy is generated via oxidative-phosphorylation
(OXPHOS) in the mitochondria and glycolysis in the cytoplasm.
In addition to providing a steady supply of energy, the metabolic
state of the cell can influence the epigenome and alter gene
expression. This flow of information is afforded by intermediate
metabolites that directly or indirectly affect the activity of chro-
matin-modifying enzymes involved in regulating chromatin dy-
namics and transcription (Katada et al., 2012; Lu and Thompson,
2012). Cellular substrate and oxygen availability, as well as en-
ergy demand, determine which metabolic pathway is used to
generate ATP. Under reduced oxygen tension, ATP is generated
via anaerobic glycolysis, whereas in aerobic conditions ATP isCeproduced mainly via OXPHOS, a process involving the break-
down of substrates to acetyl-CoA, and leading to the production
of the reduced form of nicotinamide adenine dinucleotide (NAD+)
NADH via the tricarboxylic cycle (TCA). Compared to OXPHOS,
glycolysis is an inefficient method to generate ATP. However, it
provides a number of important advantages for cells, including
the ability to rapidly generate ATP in response to acute changes
in energy demand, as well as generating the necessary glycolytic
intermediates for the biosynthesis of new macromolecules
essential for proliferating cells (Lunt and Vander Heiden, 2011;
Ryall, 2013; Shyh-Chang et al., 2013).
The enzymatic activity of sirtuin 1 (SIRT1), amember of the class
III deacetylase family (Guarente, 2000;Michan andSinclair, 2007),
is regulated by the free concentration of the intermediatemetabo-
liteNAD+ (Imai et al., 2000).Whereas a plethora of nonhistone pro-
teins are deacetylatedbySIRT1 (Houtkooper et al., 2012;Rodgers
et al., 2005), acetylated lysine 16 of histone H4 (H4K16ac) serves
as a preferred SIRT1 histone substrate (Vaquero et al., 2004).
Even though regulationof sirtuinenzymology isenergydemanding
and complex (Sauve andYoun, 2012), it establishes, in principle, a
rapid and finely tunable biochemical system through which
changes in metabolism can be effectively converted into distinct
epigenetic states and gene expression patterns.
Satellite cells (SCs) are skeletal muscle stem cells required for
muscle growth and tissue repair (Brack and Rando, 2012; Taj-
bakhsh, 2009; Yin et al., 2013). Following intense proliferation
associated with mouse postnatal muscle growth, SCs enter a
quiescent state, representing 3%–5% of the total number of
adult muscle fiber nuclei (Yin et al., 2013). In response to muscle
injury, the niche is remodeled and quiescent SCs enter the cell
cycle (become activated). Activated SCs are characterized by
the presence of the muscle-specific transcription factor MyoD,
and give rise to committed proliferating muscle precursors
which, upon expression of themyogenic transcription factor My-
ogenin, differentiate and fuse to repair damaged muscles (Taj-
bakhsh, 2009; Yin et al., 2013). Due to changes in requirements
placed on SCs during the transition from quiescence to activa-
tion, significant differences in the underlyingmetabolism of these
cellular states are likely to occur. Here we describe a metabolic
shift from fatty acid (FA) and pyruvate oxidation in quiescent SCs
to increased glycolysis and glutaminolysis during SC activation
and proliferation. In addition, we document that this process ofll Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc. 171
Figure 1. Satellite Cells Undergo a Switch
from Oxidative to Glycolytic Metabolism
following Culture in Growth Media
(A) Immunofluorescent analyses of freshly isolated
(FI, quiescent) and cultured (Cul, activated) SCs
with Pax7 (green) and MyoD (red) antibodies. 40,6-
Diamidino-2-phenylindole stain identifies nuclei.
(B) Quantification of MyoD+ SCs in FI and Cul cell
populations.
(C) RNA-seq scatter plot with key metabolic reg-
ulators indicated. Each data point represents the
mean Log2[FPKM] from two independent biolog-
ical replicates with color indicating the relative fold
change in gene expression.
(D and E) Gene ontology analyses of RNA-seq
revealed an enrichment of biological processes
specific to FI SCs (D) or Cul SCs (E). The number of
genes enriched by greater than 1.5-fold is indi-
cated under the ‘‘Count’’ column.
(F and G) Heat maps indicating absolute gene
expression (Log2[FPKM]) of specific metabolic
regulators in FI and Cul SCs. Each gene listed had
a mean fold change of greater than 1.5.
(H) RNA-seq traces (UCSC genome browser) for
Pkm 1 and 2 isoforms in FI and Cul WT SCs.
(I) Expression of the Pkm splice regulators
Hnrnpa1 and Srsf3 in FI and Cul SCs.
(J and K) Cellular bioenergetics in SCs during
culture in growth conditions were evaluated with
Seahorse XF96 bioanalyzer. Glycolysis (ECAR)
was increased 2.5-fold in Cul-3 hr and Cul-24 hr
SCs (J), whereas basal oxygen consumption
(OCR) was not different between FI, Cul-3 hr, or
Cul-24 hr SCs (K). Data are presented as mean ±
SEM. *p < 0.05 and **p < 0.01 (FI SCs versus
Cul SCs).SC metabolic reprogramming is associated with a decrease in
the intracellular NAD+/NADH ratio, reduced SIRT1-mediated de-
acetylation of H4K16ac, and activation of the myogenic pro-
gram. SCs derived from mice with muscle-specific inactivation
of the Sirt1 deacetylase domain (Sirt1mKO mice) display
increased H4K16ac and deregulated activation of the myogenic
program. Finally, Sirt1mKO mice have reduced myofiber size,
exhibit impaired muscle regeneration, and reveal a derepression
of several muscle developmental genes.
RESULTS
Quiescent Skeletal Muscle StemCells Undergo a Switch
from Fatty Acid and Pyruvate Oxidation to Glycolysis
during Culture in Growth-Permissive Conditions
To analyze transcriptomes of quiescent and proliferating SCs,
we used fluorescence-activated cell sorting (FACS) followed by
RNA sequencing (RNA-seq). FACS isolation of SCs from two172 Cell Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc.month-old C57BL/6 mouse hindlimb
muscles was based on selection of a7-
integrin+, Hoechst+, PI- and Lin- (CD11/
CD31/CD45/Sca1) cells (modified from
Kuang et al., 2007; Figures S1A–S1D
available online). Freshly isolated (FI)SCs were immediately processed following the completion of
sorting, whereas an aliquot of FACS-isolated SCs were cultured
(Cul) on collagen-coated plates in growth media for 48 hr. Quies-
cent SCs are Pax7+/MyoD, whereas activated SCs are Pax7+/
MyoD+ (Kuang et al., 2008); therefore, we analyzed aliquots of FI
or Cul SCs and confirmed them to be Pax7+/MyoD and Pax7+/
MyoD+, respectively (Figures 1A and 1B).
RNA-seq results from FI and Cul SCs identified a large number
of differentially regulated genes (Figure 1C and Table S1). Gene
ontology (GO) analyses of biological processes highlighted the
expected changes following the transition from quiescence to
proliferation, with adhesion- and homeostatic-related terms en-
riched in FI SCs (Figures 1D and S1E and Table S1), and cell-
cycle and nuclear division terms enriched in Cul SCs (Figures
1E and S1F and Table S1). Moreover, the two markers of SC
quiescence Sprouty 1 (Spry1, Shea et al., 2010) and calcitonin
receptor (Calcr, Fukada et al., 2007) were enriched in FI SCs
(Table S1). In addition, changes in a number of genes encoding
for metabolic regulators were observed in the transition from
quiescence to proliferation (Figures 1C and 1E). The expression
of genes corresponding to proteins that regulate FA metabolic
processes and lipid catabolic processes was downregulated
(Figure 1F), whereas that of genes regulating glucose catabolic
processes, glutaminolysis, macromolecular biosynthesis
(including the pentose phosphate pathway, PPP) and amino-
acid transporters was increased in Cul SCs (Figure 1G; Figures
S1G and S1H). Indicating that transcriptional activation of the
glycolytic program was not simply the result of in vitro culture
conditions, transcription of a similar subset of genes was
increased in proliferating SCs derived from regenerating skeletal
muscle (Liu et al., 2013). In addition to a global upregulation of
genes encoding glycolytic enzymes, we observed that the mus-
cle pyruvate kinase 2 (Pkm2) isoform, known to promote ‘‘aero-
bic-glycolysis’’ (or the Warburg effect), predominated over its
alternative spliced isoform Pkm1 in Cul SCs (Figure 1H). Consis-
tently, expression of Hnrnpa1 and Srsf3, two mediators of Pkm
alternative splicing, was also increased (Figure 1I).
Whereas these results are suggestive of a shift in substrate up-
take and utilization during the switch from quiescent to prolifer-
ating SCs, to directly confirm that glycolysis was elevated in
Cul SCs, we used the Seahorse extracellular flux bioanalyzer
to examine both the basal oxygen consumption rate (OCR, an in-
dicator of mitochondrial oxidative activity) and the basal extra-
cellular acidification rate (ECAR, a marker of glycolysis). We
observed a 2.5-fold increase in the ECAR (i.e., increased glycol-
ysis) in both Cul-3 hr and Cul-24 hr SCs, compared to FI SCs
(Figure 1J). However, there was no difference in the basal mito-
chondrial OCR between FI SCs and the two stages of cultured
SCs examined (Figure 1K). Because a recent study identified
an increase in mitochondria following 60 hr of SC activation
in vivo (Rodgers et al., 2014), we examined mitochondrial con-
tent in FI and Cul SCs. Similar to that observed in vivo, there
was a progressive increase in Mitotracker fluorescence in Cul
SCs during 48 hr of culture (Figure S2A) and an enrichment of
genes known to regulate the TCA cycle (Figure S2B). These re-
sults suggest that Cul SCs preferentially increase their glycolytic
rate, despite increasing their mitochondrial content. This obser-
vation is reminiscent of mouse epiblast stem cells, which have
larger and more complex mitochondria than mouse embryonic
stem cells, and yet exhibit a lower level of oxygen consumption
(Zhou et al., 2012).
Altogether, these results indicate that Cul SCs undergo a shift
away from FA oxidation, toward glycolysis, glutaminolysis, and
activation of the PPP for macromolecule biosynthesis.
SIRT1 Deacetylase Activity and NAD+ Levels Are
Elevated in Quiescent Compared to Activated Skeletal
Muscle Stem Cells
An increased reliance upon oxidative metabolism has been pro-
posed to lead to elevated SIRT1 deacetylase activity, either via
changes in absolute SIRT1 levels or changes in the NAD+/
NADH ratio (Guarente, 2011; Ryall, 2012; Figure 2A). The shift
away from FA oxidation in Cul SCs was associated with a 1.5-
fold decrease in the expression of both Sirt1 and the NAD+-
generating enzyme Nampt, as measured by qPCR (Figure 2B).
However, despite this decline, SIRT1 protein was readily de-
tected and predominantly localized to the nucleus of both FICeand Cul SCs (Figure 2C). Global H4K16ac, a substrate for
SIRT1-mediated deacetylation (Vaquero et al., 2004), was exam-
ined in SCs associated with freshly isolated single extensor dig-
itorum longus (EDL) muscle fibers, and fibers that had been
cultured in growthmedia for 3 or 20 hr (Figures 2D and 2E). Single
myofiber isolation permits SCs to remain attached to the myo-
fiber and, thus, to maintain their position in the physiological
niche between the basal lamina and the sarcolemma (Collins
and Zammit, 2009). Myofiber-associated SCs cultured in growth
media for 3 or 20 hr displayed a 7- and 16-fold increase in the
median level of H4K16ac, compared to SCs on freshly isolated
myofibers (Figures 2D and 2E), respectively. Thus, while SIRT1
protein was observed in the nucleus of Cul SCs, global
H4K16ac was strongly elevated during the early stages of cul-
ture, suggesting a possible regulation of SIRT1 activity. Because
SIRT1 deacetylase activity is dependent upon NAD+ supply (Imai
et al., 2000), we used FACS-isolated SCs to examine NAD+
levels. Whereas NADH was undetectable in both FI and Cul
SCs, the amount of total NAD+ was 10-fold higher in FI than
Cul SCs (Figure 2F). Therefore, H4K16 deacetylation, a proxy
for SIRT1 deacetylase activity, and NAD+ were elevated in FI
SCs, and reduced in Cul SCs.
Metabolic Reprogramming of Proliferating Muscle Cells
to Oxidative Phosphorylation Leads to a SIRT1-
Dependent Repression of MyoD
In contrast to glucose, for galactose to be used as an energy
substrate it must first be converted to glucose-6-phosphate in
an ATP-consuming reaction, leading to no net gain in ATP via
glycolysis (Gohil et al., 2010). Cells incubated with galactose
must therefore rely on OXPHOS to generate ATP (Figure 3A).
To test whether metabolic reprogramming affects the NAD+/
NADH ratio, H4K16ac, and muscle gene expression, we used
myogenic C2C12 cells. Although C2C12 cells do not recapitulate
all the features of SCs, they nonetheless retain some shared
characteristics. C2C12 cells incubated for 3 hr in growth media
containing galactose (10 mM) exhibited significantly reduced
glycolysis (as indicated via decreased ECAR) and increased ox-
ygen consumption (measured as OCR) compared to cells incu-
bated in growth media containing glucose (25 mM; Figure 3B).
Culturing C2C12 cells in growth media containing galactose re-
sulted in an increase of NAD+, with a concomitant decrease in
NADH, and a net 2.5-fold increase in the NAD+/NADH ratio of
cells (Figures 3C and 3D). We confirmed that incubation with
galactose did not impair ATP generation (and activate starvation
pathways), and in fact resulted in elevated levels of ATP
(Figure 3E).
The results presented in the preceding paragraphs indicate
that a switch from oxidative phosphorylation to glycolysis
accompanying SC activation has the potential to modulate the
deacetylase activity of SIRT1 via decreased NAD+ availability.
To directly test this possibility, we transduced C2C12 cells
with a SIRT1 shRNA retrovirus. The reduced SIRT1 protein
levels in these cells were associated with increased MyoD
expression, elevated global H4K16ac, and a reduced rate of
proliferation (Figures S3A and S3B). Consistent with a role of
SIRT1 in mediating these phenomena, the addition of increasing
concentrations of the SIRT1 inhibitor nicotinamide (NAM) to
proliferating C2C12 cells similarly led to an increase in globalll Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc. 173
Figure 2. The Histone Deacetylase Activity of SIRT1 Is Reduced following Satellite Cell Activation
(A) Scheme depicting how the deacetylase activity of SIRT1 is dependent on both metabolic processes (NAD+4NADH) and the NAD+ salvage pathway
(NAD+4NAM). H4K16, histone H4 lysine 16; NAD, nicotinamide adenine dinucleotide; NAM, nicotinamide; NMN, nicotinamide mononucleotide nucleosidase,
Nampt, nicotinamide phosphoribosyltransferase.
(B) Sirt1 and Nampt expression in FI and Cul SCs, as measured by qPCR (n = 3).
(C) SIRT1 and Pax7 immunofluorescence of FACS-isolated FI and Cul SCs. White scale bar represents 5 mm.
(D) Pax7 and H4K16ac immunofluorescence of SCs on freshly isolated single muscle fibers. White scale bar represents 50 mm; inset is magnified by a magnitude
of four.
(E) Quantification of relative fluorescence (RFU) in SCs labeled for H4K16ac (n = 2 mice, >50 fibers/time point). Results are presented as box-and-whisker plots,
with a significant difference indicated when the median ± 95% CI does not overlap.
(F) Total NAD levels in FI and Cul SCs (48 hr in growth media, n = 3). Data are presented as mean ± SEM, *p < 0.05 and **p < 0.01 (FI SCs versus Cul SCs).H4K16ac and MyoD expression (Figure S3C). C2C12 cells
cultured in galactose (Gal) exhibited a progressive decline in
the expression of MyoD protein levels starting at 3 hr and further
decreasing at 6 hr (Figure 3F, compare lanes 5–6, 9–10). Impor-
tantly, the galactose-induced decline in MyoD protein was abro-
gated by SIRT1 shRNA (Figure 3F, compare lanes 6 and 8, and
10 and 12), indicating a role for SIRT1 at the nexus between
changes in cellular metabolism and expression of the master
regulator MyoD.
Ablation of the SIRT1 Deacetylase Domain Leads to
Premature Differentiation of Skeletal Muscle StemCells
To investigate whether SIRT1 influences SC biology in vivo, we
generated a Pax7-specific Sirt1 knockout mouse (Sirt1muscle KO)
by crossing mice containing the Cre-recombinase under the
control of the Pax7 locus (Pax7-Cre, Keller et al., 2004) with
mice containing a modified Sirt1 gene where exon 4 (located
within the catalytic deacetylase domain) is flanked by loxP sites
(SIRT1 floxmice, Li et al., 2007). The floxed alleles were detected
in genomic DNA isolated from skeletal muscle of Cre-negative
(WT) mice, while the Dex4 alleles were detected in the presence
of Cre-recombinase in Sirt1mKO mice (Figure 4A, top). A band174 Cell Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inccorresponding to the SIRT1 protein (Figure 4A bottom, arrow)
was lost and, concomitantly, a slightly faster migrating band cor-
responding to SIRT1Dex4 appeared (Figure 4A bottom, arrow-
head), specifically in the skeletal muscles of Sirt1mKO mice,
compared with WT. Freshly isolated single EDL muscle fibers
were obtained from WT and Sirt1mKO mice, stained with Pax7
to identify SCs and costained with H4K16ac-specific antibodies.
Whereas WT myofibers had a tight distribution of SCs express-
ing low levels of global H4K16ac, SCs on Sirt1mKO myofibers
had a wider distribution of H4K16ac levels, such that there was
a 2-fold increase in the median level of global SC H4K16ac (Fig-
ures 4B and 4C). These results indicate that, in SCs, SIRT1 is
required to maintain H4K16 in a deacetylated state. Moreover,
the percentage of Pax7+/MyoD+ SCs on Sirt1mKO fibers was
increased (Figures 4D, 4E, and S3D). In light of these findings,
we asked whether Sirt1mKO SCs may also undergo premature
differentiation and, if so, whether this is a cell-autonomous phe-
nomenon. FACS-isolated SCs were cultured for 48 hr in growth
conditions, or induced to differentiate for 24 hr. Compared to
WT cells, Sirt1mKO SCs mice exhibited an overt spindle-like,
elongated morphology, indicative of early differentiation
(Figure 4F)..
Figure 3. A Forced Shift to Oxidative Metabolism Increases NAD+ Levels and Reduces MyoD in Control but Not SIRT1 shRNA Cells
(A) Schematic depicting how glucose is used to preferentially generate ATP via glycolysis. Replacing glucose with galactose forces cells to shift to predominantly
use OXPHOS for the generation of ATP.
(B) C2C12 basal cellular bioenergetics were analyzed on a Seahorse XF96 bioanalyzer during culture in either glucose or galactose based growth media (n = 15
replicates/group).
(C and D) Culturing C2C12 cells in galactose-based growthmedia increases the amount of NAD+, at the expense of NADH such that there was a 3-fold increase in
the NAD/NADH ratio (n = 3).
(E) Replacing glucose with galactose in C2C12 growth media led to an elevation in ATP levels (n = 3).
(F) Incubating C2C12 cells with galactose instead of glucose for 3 and 6 hr results in a decrease in MyoD in WT (compare lanes 5–6, and 9–10), but not SIRT1
shRNA C2C12 cells (compare lanes 7–8, and 11–12). Data are presented as mean ± SEM. *p < 0.05.SIRT1 Regulates H4K16 Acetylation and Expression
of Selected Genes
To thoroughly investigate the global impact of inactivating the
SIRT1 deacetylase activity on the transcriptome, we performed
RNA-seq on SCs derived from WT or Sirt1mKO mice at several
stages of myogenesis, including quiescence (FI), activation
(Cul), and early differentiation (Diff).
In FI Sirt1mKO SCs, 361 genes were downregulated
compared to FI WT SCs (Table S2). On the other hand, tran-
scripts corresponding to 287 genes were upregulated (Fig-
ure 5A and Table S2). Among the upregulated genes in FI
Sirt1mKO SCs were those for muscle-specific myosin light chain
kinase 2 (Mylk2; Figure 5B; Table S2), myosin light chain phos-
phorylatable (Mylpf), the skeletal muscle proteoglycan biglycan
(Bgn), and the skeletal muscle-specific ryanodine receptor 1
(Ryr1, Table S2). Expression of these genes is physiologically
observed in differentiated skeletal muscle cells. Other upregu-
lated transcripts corresponded to the BMP inhibitors chordin
(Chrd) and follistatin (Fst), known to play functional roles inCeSC proliferation and differentiation (Jeong et al., 2013; Ono
et al., 2011), and transcription factors eyes-absent 1 (Eya1-
required for somitic myogenesis, Grifone et al., 2007) and
Foxo3 (Table S2; Dentice et al., 2010). Overall, these findings
indicate a propensity of FI Sirt1mKO SCs to activate genes
physiologically expressed in activated/differentiating SCs. In
Cul Sirt1mKO SCs, 322 genes were downregulated, wheresa
253 transcripts were upregulated (Figure 5C; Table S2). Bgn,
a transcript upregulated in FI Sirt1mKO SCs, continued to be
increased, and transcripts for the decorin (Dcn) gene, whose
expression is increased during muscle regeneration of mdx
mice (Abe et al., 2009) were augmented (Table S2). Transcripts
corresponding to the H19 long noncoding (lnc) RNA were also
increased (Figure 5D). Processing of H19 lnc RNA generates
miR-675-3p and -5p, two microRNAs induced and required
for skeletal muscle differentiation (Dey et al., 2014). In Sirt1mKO
SCs induced to differentiate, 177 genes were downregulated
(Table S2) and 757 gene transcripts were increased (Figure 5E
and Table S2). The upregulated transcripts included actins,ll Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc. 175
Figure 4. Ablation of the Catalytic Domain of SIRT1 Results in Increased Global H4K16ac and Precocious Activation/Differentiation of SCs
(A) Skeletal muscle from WT mice demonstrated the presence of the Sirt1 floxed allele (fl, top) and detectable levels of SIRT1 protein (arrow, bottom), whereas
Sirt1mKO muscle contained the Sirt1Dex4 allele (D, top) and ablation of SIRT1 protein. A small level of SIRT1Dex4 protein was detectable in the skeletal muscle of
Sirt1mKO mice (arrowhead, bottom).
(B and C) In Sirt1mKO mice, quiescent SCs (identified as Pax7+) exhibited a 2-fold increase in global H4K16ac, compared to WT mice, as determined via relative
fluorescence (RFU) in SCs labeled for H4K16ac (n = 2 mice, >50 fibers/time point). White scale bar represents 50 mm; inset is magnified by a magnitude of four.
Results are presented as box-and-whisker plots (fifth to 95th percentiles), with a significant difference indicated when the median ± 95% CI does not overlap.
(D and E) MyoD and Pax7 staining (n = 2 mice, >50 fibers/time point) of fiber-associated Sirt1mKO SCs. Data are presented as mean ± SEM, *p < 0.05.
(F) DIC images of SCs isolated from WT and Sirt1mKO mice during proliferation in growth media (GM, 48 hr), or early differentiation in differentiation media (24 hr
DM). Note the overt spindle-like, elongated morphology of SCs from Sirt1mKO mice indicating premature differentiation.myosins, and troponins (Table S2). Transcription factors influ-
encing different aspects of myogenesis, such as Myog (Fig-
ure 5F), Mef2a-d, Eya4, Nfatc, Nfix, and Smad3 were also
increased (Table S2). The H19 lncRNA, upregulated in Cul (Fig-
ure 5D), was also increased in Sirt1mKO SCs induced to differ-
entiate (Figure S5C). Of particular interest, transcripts typically
expressed in either embryonic muscle and/or upregulated dur-
ing muscle regeneration including the embryonic myosin heavy
chain isoform (Myh3), filamin C (Flnc), and brain expressed 1
(Bex1) were increased in Sirt1mKO SCs (Goetsch et al., 2005;
Koo et al., 2007; Weydert et al., 1987; Table S2; Figure 7G).
Of all histone lysines, acetylation of H4K16 profoundly alters
chromatin structure by disrupting formation of the 30 nm chro-
matin fibers and preventing cross-fiber formation (Shogren-
Knaak et al., 2006). Accordingly, subtle enrichment of
H4K16ac significantly and positively affects transcription (Tay-
lor et al., 2013). To correlate transcription and H4K16ac
enrichment, 1 3 106 SCs derived from seven to eight WT
or Sirt1mKO mice were used for chromatin immunoprecipitation
sequencing (ChIP-seq) after immunoprecipitation with an176 Cell Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier IncH4K16ac antibody. H4K16 acetylation was observed to pre-
dominantly occur at and around the transcriptional start site
(TSS) and was higher in Cul SCs compared to FI SCs (Fig-
ure 6A). Moreover, there was a positive correlation between
H4K16ac and gene expression, so that the genes with the
highest expression were also the most H4K16 acetylated in
both Cul SCs (Figure 6B) and FI SCs (Figure S4A).We ad-
dressed the genome-wide role of SIRT1 on H4K16ac and
gene expression by correlating H4K16ac ChIP-seq and RNA-
seq datasets from WT and Sirt1mKO SCs. Global H4K16ac at
the 253 upregulated genes in Cul Sirt1mKO SCs was already
increased in FI Sirt1mKO SCs (Figure 6C). Similarly, H4K16ac
at the 757 genes whose transcription was increased in
Sirt1mKO SCs induced to differentiate was also increased in
FI Sirt1mKO SCs, being positioned at an intermediate
H4K16ac level between that observed in FI and Cul WT SCs
(Figure 6D). Of the 287 genes upregulated in FI Sirt1mKO
SCs, one-third (88/287, 30%, Table S3) displayed significantly
increased H4K16ac (Figure 6E). However, the vast majority of
H4K16ac was found to occur at genes whose transcription.
Figure 5. Ablation of the SIRT1 Catalytic
Domain Leads to Modifications in Gene
Expression in Both Freshly Isolated and
Cultured Satellite Cells
(A) Gene ontology (GO) of genes upregulated in FI
Sirt1mKO SCs.
(B) RNA-seq profiles (UCSC genome browser) of
the Mylk2 gene in FI WT SCs (bottom) and FI
Sirt1mKO SCs (top).
(C) GO of genes upregulated in Cul Sirt1mKO SCs.
(D) RNA-seq profiles of the H19 gene in Cul WT
SCs (bottom) and Cul Sirt1mKO SCs (top).
(E) GO of genes upregulated in Sirt1mKO SCs
induced to differentiate (24hrs DM).
(F) RNA-seq profiles of the Myog gene in WT
(bottom) and Sirt1mKO SCs (top) induced to
differentiate. RNA-seq experiments were done
with either three (FI SCs) or two (Cul and Differ-
entiating SCs) biological replicates.was not concomitantly increased (Figure 6E). In Cul Sirt1mKO
SCs, 85 of the 253 upregulated genes (33%, Table S3) had
increased H4K16ac (Figure 6E), and 275 out of the 757 upre-
gulated genes (36%, Table S3) in Sirt1mKO SCs were induced
to differentiate and manifested increased H4K16ac when as-
sayed in FI Sirt1mKO SCs (Figure 6E).
To directly analyze a link between SIRT1, H4K16ac and gene
expression, we performed SIRT1 ChIP-seq in FI and Cul SCs
(Table S4). Examples of selected genes are illustrated in genome
browser screenviews for SIRT1 ChIP-seq, H4K16ac ChIP-seq
as well as RNA-seq traces (Figures 6F and 6G; Figures S4 and
S5). SIRT1 was enriched at the Mylk2, H19, and Myog loci in
FI but absent in Cul SCs, its enrichment negatively correlating
with H4K16ac and gene transcription (Figures 6F and 6G).
H4K16 acetylation and SIRT1 enrichment at the Mylk2 and
Myog were validated using ChIP-qPCR (Figure S6). These find-
ings are in agreement with our previous results indicating a
repressive role of SIRT1 for Myog expression (Fulco et al.,
2003). Overall, the results described in this paragraph indicate
that while SIRT1 regulates the H4K16ac status at several thou-
sand loci, its deletion only permits the expression of a few hun-
dred genes.Cell Stem Cell 16, 171–183,Metabolic Reprogramming of
Skeletal Muscle Stem Cells Leads
to a SIRT1-Dependent Delay in
H4K16ac Acquisition and MyoD
Expression
To further examine the link between
metabolism, H4K16ac and SC activation,
we used isolated single fibers from WT
and Sirt1mKO mice and incubated them
for 20 hr in either glucose- (25 mM) or
galactose- (10 mM) based growth media
(Figure S7). Similarly to what observed in
C2C12 cells (Figure 3), SCs from WT
mice incubated in galactose-supple-
mented media exhibited a reduction in
global H4K16ac and MyoD expression,
compared to SCs incubated in glucosemedia (Figures S7A and S7C). In contrast, SCs from Sirt1mKO
mice did not exhibit any appreciable difference in global
H4K16ac or MyoD expression in either glucose or galactose me-
dia (Figures S7B and S7D). Overall, these results provide evi-
dence for a direct link between a change in metabolism and
SC activation and support a role for SIRT1 in this process, down-
stream of the change in metabolism.
Ablation of SIRT1 Deacetylase Activity Leads to
Developmental and Regenerative Defects in Sirt1mKO
Mice
To determine the effects of Sirt1 ablation in skeletal muscle, we
investigated phenotypic changes in Sirt1mKO mice during both
development and regeneration. Sirt1mKO mice were initially
smaller than littermate controls (Figure 7A) and had reduced
Pax7 gene and protein expression (Figures 7B and 7C). In addi-
tion, at postnatal day 9 (P9), skeletal muscles from Sirt1mKOmice
exhibited smaller fiber cross-sectional areas (CSA, Figures 7D
and 7E). By day P14, the body mass of Sirt1mKO mice became
indistinguishable from littermate controls (data not shown). Inter-
estingly, it is approximately at P14 that SCs gradually start
reducing their proliferation to enter quiescence at P21 (ChangFebruary 5, 2015 ª2015 Elsevier Inc. 177
Figure 6. Ablation of the SIRT1 Catalytic Domain Alters H4K16 Acetylation and Influences Expression of Selected Genes
(A) Average signal of normalized tag density for H4K16ac ChIP-seq in FI WT SCs (blue line) and Cul WT SCs (red line).
(B) Average signal of normalized tag density for H4K16ac ChIP-seq in Cul WT SCs for genes with low (green line), medium-low (blue line), medium-high (red line),
and high expression (black line).
(C) Average signal of normalized tag density for H4K16ac ChIP-seq in FI WT SCs (blue line), FI Sirt1mKO SCs (green line), and Cul WT SCs for genes upregulated in
Cul Sirt1mKO SCs.
(D) Average signal of normalized tag density for H4K16ac ChIP-seq in FI WT SCs (blue line), FI Sirt1mKO SCs (green line), and Cul WT SCs induced to differentiate
for genes upregulated in Sirt1mKO induced to differentiate.
(legend continued on next page)
178 Cell Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc.
Figure 7. Loss of SIRT1 Deacetylase Activ-
ity Leads to Developmental and Regenera-
tive Defects in Skeletal Muscle
(A) Body mass was evaluated starting at postnatal
(P) days 5 through 9 in WT and Sirt1mKO mice (WT
n = 27; Sirt1mKO = 24). Significance was deter-
mined using a Student’s t test (two-tailed distri-
bution without assuming equal variance).
(B and C) Pax7mRNA (left) and protein expression
(right) were evaluated in the skeletal muscles of P9
WT and Sirt1mKO mice.
(D) Hematoxylin and eosin (H&E) staining of skel-
etal muscles in P9 WT and Sirt1mKO mice. White
scale bar represents 50 mM.
(E) Quantification of skeletal muscle fiber CSA
from P9 mice (>1,000 fibers analyzed/muscle).
Results are presented as a box-and-whisker plot.
(F) Heatmap of the microarray results (Log2[signal
intensity]) for genes upregulated in Sirt1mKO skel-
etal muscle. Each gene listed has a mean fold
change of >1.5 and p < 0.05 (n = 3 samples/
group).
(G) Heatmap of the microarray results (Log2[signal
intensity]) for genes upregulated in both Sirt1mKO
SCs induced to differentiate and Sirt1mKO skeletal
muscle, with developmentally regulated muscle
genes highlighted in yellow.
(H) Gene ontology for genes upregulated in both
Sirt1mKO SCs induced to differentiate andSirt1mKO
skeletal muscle.
(I) H&E skeletal muscle staining of 2-month-old
(adult) WT and Sirt1mKO mice 7 days after CTX
injection.
(J) Quantification of skeletal muscle fiber CSA
from adult WT and Sirt1mKO mice regenerating
muscles (7 days after CTX, >1,000 fibers
analyzed/muscle). Results are presented as a
box-and-whisker plot. (K) Pax7 protein levels in
uninjured, and 7 and 14 days regenerating mus-
cles of WT and Sirt1mKO mice. Data are presented
as mean ± SEM, *p < 0.05; **p < 0.01.and Rudnicki, 2014). Amicroarray assay of RNA derived from the
gastrocnemius hindlimb muscles revealed an enrichment of 219
and a reduction of 191 transcripts in the muscles of Sirt1mKO
compared to WT mice (Figure 7F and Table S5). Of the upregu-
lated transcripts in Sirt1mKO muscle, 28 (corresponding to 12%
of the total transcripts) were also increased in Sirt1mKO SCs
induced to differentiate (Figure 7G and Table S5). A GO analysis
of the transcripts upregulated in both Sirt1mKO muscle and
Sirt1mKOSCs returned biological terms related to skeletal muscle
development (‘‘myofibril,’’ ‘‘sarcomere,’’ and ‘‘striated muscle
development,’’ Figure 7H). The most highly upregulated tran-
script in Sirt1mKO muscles corresponded to the embryonic(E) Venn diagram representing genes upregulated in FI Sirt1mKO SCs (287 gene
(757 genes), and genes acquiring H4K16ac in FI Sirt1mKO SCs (7,189 genes).
(F) ChIP-seq and RNA-seq profiles of theMylk2 gene. Bottom to top: SIRT1 ChIP
SIRT11mKO SCs, and WT Cul SCs (magenta signals); Mylk2 mRNA expression p
(G) ChIP-seq and RNA-seq profiles of the Myog gene. Bottom to top: SIRT1 Ch
Sirt1mKO FI SCs, and WT Cul SCs (magenta signals); Myog mRNA expression pr
Cemyosin heavy chain isoform Myh3 (5.8-fold increase, Table
S5), which is physiologically expressed in fetal muscle and
repressed in the adult (Weydert et al., 1987). In addition to
Myh3, several other transcripts upregulated in both Sirt1mKO
muscles and Sirt1mKO SCs induced to differentiate are known
to be preferentially expressed during muscle development
and/or in regenerating muscles (highlighted in Figure 7G,
Table S5).
In response to injury, quiescent SCs become activated, enter
mitosis, giving rise tomyogenic progenitor cells, which ultimately
differentiate to restore damaged muscles (Chang and Rudnicki,
2014). To evaluate whether muscle regeneration was altered ins), Cul Sirt1mKO SCs (253 genes), and Sirt1mKO SCs induced to differentiate
-seq profile in FI and Cul WT SCs (blue signals); H4K16ac profile in FI WT and
rofile in FI WT and Sirt1mKO SCs (black signals).
IP-seq profile in FI and Cul WT SCs (blue signals); H4K16ac profile in WT and
ofile in FI WT and Sirt1mKO SCs (black signals).
ll Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc. 179
Sirt1mKO mice, muscle damage was induced by injecting the ti-
bialis anterior (TA) muscles of 2-month-old WT or Sirt1mKO
mice with the myogenic agent cardiotoxin (CTX). Seven days af-
ter CTX injection, regenerating muscles of Sirt1mKO mice were
composed of myofibers with smaller CSA (Figures 7H and 7I),
and reduced Pax7 protein (Figure 7J, both at 7 and 14 days after
CTX injection), compared to littermate controls. Overall, these
findings indicate that SIRT1 is required for appropriate postnatal
muscle growth and adult muscle regeneration.
DISCUSSION
In this study, SIRT1 was found to lie at the nexus between SC
metabolic reprogramming and muscle gene expression. Our
findings are consistent with a model wherein the metabolic state
influences the gene expression program of SCs via modulation
of the metabolite NAD+ and SIRT1 deacetylase activity. Ablation
of a SIRT1 domain conferring deacetylase activity resulted in
widespread H4K16ac and derepression of several hundred
genes in SCs. However, such hyperacetylation did not result in
a generalized and immediate transcriptional response of all
target genes. For instance, enrichment of H4K16ac at the
Myog locus was increased in FI Sirt1mKO SCs but its expression
was augmented only in Sirt1mKO SCs induced to differentiate.
Local chromatin architecture and additional transcriptional
events—including histone dynamics and transcription factor
availability—likely determine whether, at specific loci, transcrip-
tional derepression is concomitant with SIRT1 removal or will
occur at later stages of cell differentiation. Furthermore, that
only approximately 30%–40% of the genes derepressed upon
Sirt1 ablation acquired H416ac indicates that either additional
histone lysines or nonhistone substrates are involved in SIRT1-
mediated transcriptional repression (Houtkooper et al., 2012).
It is interesting to note that SIRT1 does not appear to regulate
the expression of metabolic regulators. Thus, although SIRT1 re-
sponds to the process of SC metabolic reprogramming by influ-
encing H4K16 acetylation and gene expression, it does not play
a direct role in the observed switch toward glycolysis in prolifer-
ating SCs. Despite the presence of MyoD+ SCs on Sirt1mKO fi-
bers, the corresponding Myod1 transcripts were not elevated.
This observation is consistent with findings reporting that
Myod1 transcripts are already present in quiescent SCs, not ex-
hibiting a significant increase during SC activation in vivo (Kani-
sicak et al., 2009; Liu et al., 2013; Pallafacchina et al., 2010;
Rodgers et al., 2014). Analogous to microRNA-mediated Myf5
regulation (Crist et al., 2012), posttranscriptional processing of
Myod1 mRNA transcripts may be responsible for the appear-
ance of the MyoD protein in activated SCs. Moreover, while
increasedMyog transcripts in Cul (24 hr DM)Sirt1mKO SCs corre-
lated with the enrichment of H4K16ac at its locus in quiescent
Sirt1mKO SCs, and SIRT1 disengagement in cultured WT SCs,
we cannot exclude that additional regulatory mechanisms
controlled by SIRT1 also contribute toMyog activation. In this re-
gard, SIRT1 deacetylates the histone acetyltransferases PCAF
and p300, and transcription factors MyoD and Foxo3 (Brunet
et al., 2004; Fulco et al., 2003; Motta et al., 2004), making it plau-
sible that nonhistone substrates relevant to myogenesis are
affected in Sirt1mKO SCs. Recently, SIRT1 has been implicated
in regulating autophagic flux and SC activation (Tang andRando,180 Cell Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc2014). In this study, authophagy in fiber-associated SCs was de-
tected after 24–36 hr of culture, during which time SCs had
entered the S phase of the cell cycle, as measured via an 5-ethy-
nyl-20-deoxyuridine (EdU) assay. Interestingly, using an inducible
SC-specific SIRT1-KO mouse (Pax7CreERT2xSirt1fl/fl), these au-
thors demonstrated that Sirt1 ablation inhibited autophagic flux
and delayed entry into the S phase of the cell cycle. The different
timing used to evaluate SC activation, along with the mode of
SIRT1 excision (inducible versus constitutive) and the use of
MyoD versus EdU as a measure of SC activation, may account
for the observed differences between this study and the current
results.
Altogether, our findings suggest a role for metabolism in the
regulation of SC biology, beyond simply providing the building
blocks and ATP required for new cell growth. Within this context,
it has previously been shown that the generation of nucleocyto-
plasmic acetyl-CoA is dependent upon glycolytic production of
citrate (Wellen et al., 2009). In contrast, FA oxidation leads to
the production of mitochondrial acetyl-CoA for entry into the
TCA cycle (Wellen et al., 2009). Thus, any shift toward glycolysis
would be expected to lead to both a decrease in SIRT1 deacety-
lase activity (through reduced NAD+), and an increased supply of
acetyl-CoA for histone/protein acetylation, and together likely
explain the observed increase in global H4K16ac in active
SCs. There is previous evidence that the behavior of adult SCs
is influenced by regulatory pathways controlled by oxygen ten-
sion and metabolic states (Csete et al., 2001; Liu et al., 2012).
A link between metabolism and SC function has been proposed,
with recent studies indicating a link between OXPHOS and SC
clonogenic capacity. Elevated mitochondrial abundance and
OXPHOS activity, induced by calorie restriction (CR), was found
to be associated with an increase in the number of cells capable
of initiating myogenic colony formation (Cerletti et al., 2012).
Regulation of MyoD and Myogenin by increased SIRT1 activity
elicited by CRwould keep SCs in a stem-like state and favor their
clonogenicity. Consistent with this, both the SIRT1 level and the
metabolic milieu conducive to its activation were augmented in
SCs derived from CR animals (Cerletti et al., 2012). A similar in-
crease in clonogenic capacity was observed in HSC with
increased FA oxidation (Ito et al., 2012) while, more recently,
glucose and glutamine metabolism has been reported to regu-
late human HSC lineage specification (Oburoglu et al., 2014).
Finally, our gene expression profiling of whole muscles re-
vealed deregulated transcription in Sirt1mKO mice. Intriguingly,
a subset of the upregulated transcripts was also increased in
Sirt1mKO SCs induced to differentiate (Figure 7G). Because in
adult mice SCs have completed their differentiation process to
give rise to mature myofibers, we interpret these findings to indi-
cate that the upregulated transcripts identified in Sirt1mKO mus-
cles derive from the myofiber compartment. The presence of
such transcripts in both differentiating Sirt1mKO SCs and
Sirt1mKO adult muscles suggests that their deregulation likely
originates in SCs and is further maintained in the adult muscle.
In summary, our results provide insights into the developing
paradigm linking the process of metabolic reprogramming, tran-
scriptional regulation, and acquisition of defined cell states. In
the absence of SIRT1, quiescent SCs lose their respective blue-
print of carefully regulated H4K16ac and undergo a progressive
deregulation of gene expression during activation and.
differentiation. We conclude that metabolic modifications affect
the activity of SIRT1, which acts as a relay able to interpret the
rapid change in metabolism (via NAD+) and induce subsequent
changes in H4K16 acetylation status and gene expression.EXPERIMENTAL PROCEDURES
Full details are provided in the Supplemental Experimental Procedures.
Fluorescence-Activated Cell Sorting
SCs were sorted based on our previously described technique (Juan et al.,
2011), which utilizes a modified version of the method described by Kuang
et al. (2007). Briefly, hindlimb muscles from mice were digested with 0.2%
collagenase for 60 min and SCs were liberated by treating the resultant slurry
with collagenase/dispase. All cells were incubated with primary antibodies
raised against a7-integrin, and PE-labeled CD11, CD31, CD45, and Sca1,
and Hoechst 33342 (10 mg/ml) and PI (30 min). SCs were isolated via FACS,
gating on positive a7-integrin and Hoechst staining, and negative PI and PE-
CD/11/CD31/CD45/Sca1 staining.
Single Muscle Fiber Isolation and Culture
Single EDL fibers were isolated and cultured as previously described (Juan
et al., 2011). Briefly, single fibers were liberated in a collagenase solution
and then immediately fixed in 4% paraformaldehyde, or cultured in growth
media for the specified time (see Supplemental Experimental Procedures
for growth media conditions). Measurements of relative fluorescent units
(RFU) were completed via ImageJ (NIH) and represent gray intensity multi-
plied by nuclear size (see Supplemental Experimental Procedures for
details).
Chromatin Immunoprecipitation
For ChIP-seq,13 106 SCs (isolated via FACS from the hindlimbs of seven to
eight mice) were immediately crosslinked (for FI SCs) or cultured for 48 hr (Cul
SCs) and subsequently crosslinked in 1% formaldehyde and processed ac-
cording to published protocols (Me´tivier et al., 2003; Mousavi et al., 2012).
Briefly, cells were lysed in RIPA buffer (13 PBS, 1% NP-40, 0.5% sodium de-
oxycholate, 0.1% SDS) and centrifuged at 2,000 revolutions per minute for
5 min. The chromatin fraction was sheared by sonication (4 3 30sec) in
1.5 ml siliconized Eppendorf tubes. The resulting sheared chromatin samples
were cleared for 1 hr, immunoprecipitated overnight, and washed in buffer I
(20 mM TrisHCl [pH 8.0], 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 1% Triton
X-100), buffer II (20 mM TrisHCl [pH 8.0], 500 mM NaCl, 2 mM EDTA, 0.1%
SDS, 1% Triton X-100), buffer III (10 mM TrisHCl [pH 8.0], 250 mM LiCl, 1%
NP- 40; 1% sodium deoxycholate, 1 mM EDTA), and Tris-EDTA (pH 8.0). All
washes were performed at 4C for 5 min. Finally, crosslinking was reversed




Oxygen consumption and extracellular acidification rates of both SCs and
C2C12 cells were measured on an extracellular flux bioanalyzer (XF96,
Seahorse Biosciences), and seeded at a density of 50,000 and 12,000
cells per well, respectively (see Supplemental Experimental Procedures
for details).
Mice
The initial characterization of the metabolic profile of SCs was conducted in
WT mice (C57BL/6 background). Sirt1mKO mice were generated via breeding
of Pax7cre/+ knockin mice (Keller et al., 2004) with mice containing the floxed
exon 4 Sirt1 allele (Li et al., 2007). Skeletal muscle injury was induced via a sin-
gle intramuscular injection of the snake venom cardiotoxin to the TA muscle.
Briefly, cardiotoxin (20 mg/ml) was injected into the TAmuscle until themaximal
holding capacity of the muscle was reached (30–50 ml). In all cases using
Sirt1mKO mice, littermates were used as controls. All experiments were per-
formed according to the NIH Animal Care and Use regulations.CeStatistical Analyses
All data are presented as mean ± SEM, excluding RFU measurements of
H4K16ac and MyoD and muscle fiber CSA, which are expressed as box-
and-whisker plots. Statistical analyses were performed using a Student’s t
test to calculate differences between two groups, or a two-way ANOVA fol-
lowed by a Tukey’s post hoc analysis for multiple comparisons. For data pre-
sented as box-and-whisker plots, data were determined to be statistically
different when the median ± 95% CI did not overlap.ACCESSION NUMBERS
The Gene Expression Omnibus accession number for RNA-seq and ChIP-seq
datasets reported in this paper is GSE64379.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and five tables and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2014.12.004.
AUTHOR CONTRIBUTIONS
J.G.R, S.D., and V.S. designed the experiments and wrote the manuscript.
J.G.R. performed most of the presented experiments. S.D. performed RNA-
seq and ChIP-seq experiments. A.D. performed FACS and RNA-seq experi-
ments. A.J. performed single fiber isolation and immunofluorescence staining.
H.Z. conducted bioinformatics analysis of RNA-seq and ChIP-seq data. X.F.
performedmuscle injury experiments, muscle sectioning, and immunofluores-
cence staining and helped with animal breeding. D.C performed FACS exper-
iments. M.K. supervised animal breeding and analyzed animal body mass.
G.G.-C. prepared libraries for RNA-seq and ChIP-seq and performed
sequencing. M.F. provided technical and intellectual advice.
ACKNOWLEDGMENTS
We thank Yansong Gu (University of Washington, Seattle) for sharing the Sirt1
floxed mice, Kristina Zaal (Light Imaging Section, National Institute of Arthritis
and Musculoskeletal and Skin Diseases [NIAMS]) for help in evaluating Pax7+/
MyoD+ immunofluorescence staining, and Jim Simone (Flow Cytometry Sec-
tion, NIAMS) for help with FACS. J.G.R. was supported, in part, via an Over-
seas Biomedical Research Fellowship from the National Health & Medical
Research Council of Australia. This work was supported by the Intramural
Research Program of NIAMS at the NIH.
Received: November 19, 2013
Revised: August 27, 2014
Accepted: December 16, 2014
Published: January 15, 2015
REFERENCES
Abe, S., Hirose, D., Kado, S., Iwanuma, O., Saka, H., Yanagisawa, N., and Ide,
Y. (2009). Increased expression of decorin during the regeneration stage of
mdx mouse. Anat. Sci. Int. 84, 305–311.
Brack, A.S., and Rando, T.A. (2012). Tissue-specific stem cells: lessons from
the skeletal muscle satellite cell. Cell Stem Cell 10, 504–514.
Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., Tran,
H., Ross, S.E., Mostoslavsky, R., Cohen, H.Y., et al. (2004). Stress-dependent
regulation of FOXO transcription factors by the SIRT1 deacetylase. Science
303, 2011–2015.
Cerletti, M., Jang, Y.C., Finley, L.W., Haigis, M.C., and Wagers, A.J. (2012).
Short-term calorie restriction enhances skeletal muscle stem cell function.
Cell Stem Cell 10, 515–519.
Chang, N.C., and Rudnicki, M.A. (2014). Satellite cells: the architects of skel-
etal muscle. Curr. Top. Dev. Biol. 107, 161–181.ll Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc. 181
Collins, C.A., and Zammit, P.S. (2009). Isolation and grafting of single muscle
fibres. Methods Mol. Biol. 482, 319–330.
Crist, C.G., Montarras, D., and Buckingham, M. (2012). Muscle satellite cells
are primed for myogenesis but maintain quiescence with sequestration of
Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell 11,
118–126.
Csete, M., Walikonis, J., Slawny, N., Wei, Y., Korsnes, S., Doyle, J.C., and
Wold, B. (2001). Oxygen-mediated regulation of skeletal muscle satellite cell
proliferation and adipogenesis in culture. J. Cell. Physiol. 189, 189–196.
Dentice, M., Marsili, A., Ambrosio, R., Guardiola, O., Sibilio, A., Paik, J.H.,
Minchiotti, G., DePinho, R.A., Fenzi, G., Larsen, P.R., and Salvatore, D.
(2010). The FoxO3/type 2 deiodinase pathway is required for normal mouse
myogenesis and muscle regeneration. J. Clin. Invest. 120, 4021–4030.
Dey, B.K., Pfeifer, K., and Dutta, A. (2014). The H19 long noncoding RNA gives
rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle
differentiation and regeneration. Genes Dev. 28, 491–501.
Fukada, S., Uezumi, A., Ikemoto, M., Masuda, S., Segawa, M., Tanimura, N.,
Yamamoto, H., Miyagoe-Suzuki, Y., and Takeda, S. (2007). Molecular signa-
ture of quiescent satellite cells in adult skeletal muscle. Stem Cells 25,
2448–2459.
Fulco, M., Schiltz, R.L., Iezzi, S., King, M.T., Zhao, P., Kashiwaya, Y., Hoffman,
E., Veech, R.L., and Sartorelli, V. (2003). Sir2 regulates skeletal muscle differ-
entiation as a potential sensor of the redox state. Mol. Cell 12, 51–62.
Goetsch, S.C., Martin, C.M., Embree, L.J., and Garry, D.J. (2005). Myogenic
progenitor cells express filamin C in developing and regenerating skeletal
muscle. Stem Cells Dev. 14, 181–187.
Gohil, V.M., Sheth, S.A., Nilsson, R., Wojtovich, A.P., Lee, J.H., Perocchi, F.,
Chen, W., Clish, C.B., Ayata, C., Brookes, P.S., and Mootha, V.K. (2010).
Nutrient-sensitized screening for drugs that shift energy metabolism from
mitochondrial respiration to glycolysis. Nat. Biotechnol. 28, 249–255.
Grifone, R., Demignon, J., Giordani, J., Niro, C., Souil, E., Bertin, F., Laclef, C.,
Xu, P.X., andMaire, P. (2007). Eya1 and Eya2 proteins are required for hypaxial
somitic myogenesis in the mouse embryo. Dev. Biol. 302, 602–616.
Guarente, L. (2000). Sir2 links chromatin silencing, metabolism, and aging.
Genes Dev. 14, 1021–1026.
Guarente, L. (2011). Sirtuins, aging, andmetabolism. Cold Spring Harb. Symp.
Quant. Biol. 76, 81–90.
Houtkooper, R.H., Pirinen, E., and Auwerx, J. (2012). Sirtuins as regulators of
metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225–238.
Imai, S., Armstrong, C.M., Kaeberlein, M., and Guarente, L. (2000).
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent his-
tone deacetylase. Nature 403, 795–800.
Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D.E., Schafer, Z.T.,
Evans, R.M., Suda, T., Lee, C.H., and Pandolfi, P.P. (2012). A PML–PPAR-
d pathway for fatty acid oxidation regulates hematopoietic stem cell mainte-
nance. Nat. Med. 18, 1350–1358.
Jeong, J., Conboy, M.J., and Conboy, I.M. (2013). Pharmacological inhibition
of myostatin/TGF-b receptor/pSmad3 signaling rescues muscle regenerative
responses in mouse model of type 1 diabetes. Acta Pharmacol. Sin. 34,
1052–1060.
Juan, A.H., Derfoul, A., Feng, X., Ryall, J.G., Dell’Orso, S., Pasut, A., Zare, H.,
Simone, J.M., Rudnicki, M.A., and Sartorelli, V. (2011). Polycomb EZH2 con-
trols self-renewal and safeguards the transcriptional identity of skeletal muscle
stem cells. Genes Dev. 25, 789–794.
Kanisicak, O., Mendez, J.J., Yamamoto, S., Yamamoto, M., and Goldhamer,
D.J. (2009). Progenitors of skeletal muscle satellite cells express the muscle
determination gene, MyoD. Dev. Biol. 332, 131–141.
Katada, S., Imhof, A., and Sassone-Corsi, P. (2012). Connecting threads: epi-
genetics and metabolism. Cell 148, 24–28.
Keller, C., Hansen, M.S., Coffin, C.M., and Capecchi, M.R. (2004). Pax3:Fkhr
interferes with embryonic Pax3 and Pax7 function: implications for alveolar
rhabdomyosarcoma cell of origin. Genes Dev. 18, 2608–2613.182 Cell Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier IncKoo, J.H., Smiley, M.A., Lovering, R.M., and Margolis, F.L. (2007). Bex1 knock
out mice show altered skeletal muscle regeneration. Biochem. Biophys. Res.
Commun. 363, 405–410.
Kuang, S., Kuroda, K., Le Grand, F., and Rudnicki, M.A. (2007). Asymmetric
self-renewal and commitment of satellite stem cells in muscle. Cell 129,
999–1010.
Kuang, S., Gillespie, M.A., and Rudnicki, M.A. (2008). Niche regulation of mus-
cle satellite cell self-renewal and differentiation. Cell Stem Cell 2, 22–31.
Li, H., Rajendran, G.K., Liu, N., Ware, C., Rubin, B.P., and Gu, Y. (2007). SirT1
modulates the estrogen-insulin-like growth factor-1 signaling for postnatal
development of mammary gland in mice. Breast Cancer Res. 9, R1.
Liu, W., Wen, Y., Bi, P., Lai, X., Liu, X.S., Liu, X., and Kuang, S. (2012). Hypoxia
promotes satellite cell self-renewal and enhances the efficiency of myoblast
transplantation. Development 139, 2857–2865.
Liu, L., Cheung, T.H., Charville, G.W., Hurgo, B.M., Leavitt, T., Shih, J., Brunet,
A., and Rando, T.A. (2013). Chromatin modifications as determinants of mus-
cle stem cell quiescence and chronological aging. Cell Rep. 4, 189–204.
Lu, C., and Thompson, C.B. (2012). Metabolic regulation of epigenetics. Cell
Metab. 16, 9–17.
Lunt, S.Y., and Vander Heiden, M.G. (2011). Aerobic glycolysis: meeting the
metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27,
441–464.
Me´tivier, R., Penot, G., Hu¨bner, M.R., Reid, G., Brand, H., Kos, M., and
Gannon, F. (2003). Estrogen receptor-alpha directs ordered, cyclical, and
combinatorial recruitment of cofactors on a natural target promoter. Cell
115, 751–763.
Michan, S., and Sinclair, D. (2007). Sirtuins in mammals: insights into their bio-
logical function. Biochem. J. 404, 1–13.
Motta, M.C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma,
Y., McBurney, M., and Guarente, L. (2004). Mammalian SIRT1 represses fork-
head transcription factors. Cell 116, 551–563.
Mousavi, K., Zare, H., Wang, A.H., and Sartorelli, V. (2012). Polycomb protein
Ezh1 promotes RNA polymerase II elongation. Mol. Cell 45, 255–262.
Oburoglu, L., Tardito, S., Fritz, V., de Barros, S.C., Merida, P., Craveiro, M.,
Mamede, J., Cretenet, G., Mongellaz, C., An, X., et al. (2014). Glucose and
glutamine metabolism regulate human hematopoietic stem cell lineage spec-
ification. Cell Stem Cell 15, 169–184.
Ono, Y., Calhabeu, F., Morgan, J.E., Katagiri, T., Amthor, H., and Zammit, P.S.
(2011). BMP signalling permits population expansion by preventing premature
myogenic differentiation in muscle satellite cells. Cell Death Differ. 18,
222–234.
Pallafacchina, G., Franc¸ois, S., Regnault, B., Czarny, B., Dive, V., Cumano, A.,
Montarras, D., andBuckingham,M. (2010). An adult tissue-specific stem cell in
its niche: a gene profiling analysis of in vivo quiescent and activated muscle
satellite cells. Stem Cell Res. (Amst.) 4, 77–91.
Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., and
Puigserver, P. (2005). Nutrient control of glucose homeostasis through a com-
plex of PGC-1alpha and SIRT1. Nature 434, 113–118.
Rodgers, J.T., King, K.Y., Brett, J.O., Cromie, M.J., Charville, G.W., Maguire,
K.K., Brunson, C., Mastey, N., Liu, L., Tsai, C.R., et al. (2014). mTORC1 con-
trols the adaptive transition of quiescent stem cells from G0 to G(Alert).
Nature 510, 393–396.
Ryall, J.G. (2012). The role of sirtuins in the regulation of metabolic homeosta-
sis in skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 15, 561–566.
Ryall, J.G. (2013). Metabolic reprogramming as a novel regulator of skeletal
muscle development and regeneration. FEBS J. 280, 4004–4013.
Sauve, A.A., and Youn, D.Y. (2012). Sirtuins: NAD(+)-dependent deacetylase
mechanism and regulation. Curr. Opin. Chem. Biol. 16, 535–543.
Shea, K.L., Xiang, W., LaPorta, V.S., Licht, J.D., Keller, C., Basson, M.A., and
Brack, A.S. (2010). Sprouty1 regulates reversible quiescence of a self-renew-
ing adult muscle stem cell pool during regeneration. Cell StemCell 6, 117–129..
Shogren-Knaak, M., Ishii, H., Sun, J.M., Pazin, M.J., Davie, J.R., and Peterson,
C.L. (2006). Histone H4-K16 acetylation controls chromatin structure and pro-
tein interactions. Science 311, 844–847.
Shyh-Chang, N., Daley, G.Q., and Cantley, L.C. (2013). Stem cell metabolism
in tissue development and aging. Development 140, 2535–2547.
Tajbakhsh, S. (2009). Skeletal muscle stem cells in developmental versus
regenerative myogenesis. J. Intern. Med. 266, 372–389.
Tang, A.H., and Rando, T.A. (2014). Induction of autophagy supports the bio-
energetic demands of quiescent muscle stem cell activation. EMBO J. 33,
2782–2797.
Taylor, G.C., Eskeland, R., Hekimoglu-Balkan, B., Pradeepa, M.M., and
Bickmore, W.A. (2013). H4K16 acetylation marks active genes and enhancers
of embryonic stem cells, but does not alter chromatin compaction. Genome
Res. 23, 2053–2065.CeVaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., and
Reinberg, D. (2004). Human SirT1 interacts with histone H1 and promotes for-
mation of facultative heterochromatin. Mol. Cell 16, 93–105.
Wellen, K.E., Hatzivassiliou, G., Sachdeva, U.M., Bui, T.V., Cross, J.R., and
Thompson, C.B. (2009). ATP-citrate lyase links cellular metabolism to histone
acetylation. Science 324, 1076–1080.
Weydert, A., Barton, P., Harris, A.J., Pinset, C., and Buckingham, M. (1987).
Developmental pattern of mouse skeletal myosin heavy chain gene transcripts
in vivo and in vitro. Cell 49, 121–129.
Yin, H., Price, F., and Rudnicki, M.A. (2013). Satellite cells and themuscle stem
cell niche. Physiol. Rev. 93, 23–67.
Zhou, W., Choi, M., Margineantu, D., Margaretha, L., Hesson, J., Cavanaugh,
C., Blau, C.A., Horwitz, M.S., Hockenbery, D., Ware, C., and Ruohola-Baker,
H. (2012). HIF1a induced switch from bivalent to exclusively glycolytic meta-
bolism during ESC-to-EpiSC/hESC transition. EMBO J. 31, 2103–2116.ll Stem Cell 16, 171–183, February 5, 2015 ª2015 Elsevier Inc. 183
